Rethinking pediatric clinical trials: guidelines from pediatric experts
In this last episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
Working in collaboration with patient associations: insights from Estelle Haenel, Kayentis Medical Director
Whilst we hear a lot about working in collaboration with patient representatives, not so many industrial stakeholders are actually doing it. Establishing true and valuable collaborations with patients can be very simple and has so much value: why still hesitate?
Watch this interview where Estelle Haenel, Medical Director at Kayentis, reflects on the partnerships she has established with patient representatives and associations:
In this last episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
In this third episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
Integrating PROs into studies on MASH, also known as NASH, is crucial. MASH is a debilitating
Asthma clinical trials present several specificities, such as the use of disease-specific health-related quality of
NonAlcoholic SteatoHepatitis (NASH), now called Metabolic Dysfunction-Associated SteatoHepatitis (MASH), affects almost 115 million adults globally
In this second episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
Last update : 19 January 2023